| Typicality: | 0.460 |
| Saliency: | 0.492 |
| in patients with bronchospastic disease | 7 | transitive-object |
| because of its relative beta1 selectivity | 3 | cause |
| atenolol → be used with → caution | 9 |
| negative | neutral | positive |
| 0.440 | 0.517 | 0.043 |
| Raw frequency | 9 |
| Normalized frequency | 0.492 |
| Modifier score | 0.500 |
| Perplexity | 25.658 |